GHK-Cu peptide claims on TikTok: what the science actually supports

What did @ashengland03 actually say?

The creator's core argument is that injecting GHK-Cu (copper peptide) is not recklessness, it's informed biology. She frames it as women in their 40s moving past "cute" topical serums toward "systemic support" for collagen signaling, hair growth, circulation, and tissue repair. Her exact framing: "things that your cute little expensive serum could never touch." That's a strong claim, and it deserves a serious look.

She also name-checks that GHK-Cu has been studied for a long time, which is true. The peptide was first isolated in human plasma by Loren Pickart in the early 1970s. This is not some basement-synthesized compound with zero research history. That part she got right, and it matters.

Does the science back this up?

Partially, yes. The topical versus injectable distinction she draws has some real basis in absorption research, but it is not as clean as she makes it sound. GHK-Cu has a reasonably solid evidence base, mostly in vitro and animal models, with some human clinical data for topical use.

On collagen signaling: Pickart and Margolina (2018, Biomolecules) reviewed GHK-Cu's role in activating genes associated with collagen and elastin synthesis. That's real. Finkley et al. (2007, Journal of Investigative Dermatology) showed topical GHK-Cu improved skin density and reduced fine lines in a randomized controlled trial. So topical is not entirely without evidence, which undercuts her "serums could never touch" line a bit.

For injected GHK-Cu specifically, the human clinical data is thin. Most systemic effect studies are animal-based. The leap from "studied peptide" to "injectable systemic support with proven outcomes" is not fully supported by the current literature.

What did they get wrong (or right)?

She got the biology of aging broadly right. Collagen production does decline significantly after 40. A 2012 study by Varani et al. in Archives of Dermatology confirmed fibroblast function and procollagen synthesis both drop with age. Inflammation does increase with age, a phenomenon researchers call inflammaging, documented by Franceschi et al. (2000, Annals of the New York Academy of Sciences). That framing is legitimate.

What she got wrong is the certainty. Saying injected GHK-Cu delivers "deeper collagen signaling, hair growth, better circulation, tissue repair" as if these are established outcomes misrepresents the evidence. Hair growth research on GHK-Cu is mostly murine models. Circulation effects are preliminary. She presents a research-supported compound as if the injectable route has been clinically validated for all these outcomes. It has not been, at least not in robust human trials.

She also skips the safety and regulatory context entirely. GHK-Cu sold for injection is a compounded or research-grade product. That is a meaningful distinction she owes her audience.

What should you actually know?

GHK-Cu is a legitimate area of scientific inquiry. It is not a scam compound, and the research interest is real. But "studied" does not mean "proven effective when injected in humans." Those are different claims, and conflating them is where this video goes sideways.

If you are considering injectable peptides, the regulatory reality matters. Compounded GHK-Cu is not FDA-approved for any indication. It is not the same as a pharmaceutical-grade product. That does not make it automatically dangerous, but it does mean quality control, dosing, and sourcing are all variables you cannot ignore.

The creator is right that informed women in their 40s are a real and growing population seeking evidence-based options beyond standard skincare. That framing deserves respect. But informed means understanding what the evidence actually shows, including its limits, not just finding studies that sound supportive. A telehealth provider or physician who specializes in peptide therapy is the right person to evaluate whether GHK-Cu makes sense for your individual situation.

Bottom line

GHK-Cu has real science behind it, particularly for collagen-related signaling and wound healing contexts. The creator earns credit for not inventing the compound or misidentifying it. Where she oversells is in treating the injectable route as an obviously superior, well-proven option when the human clinical data, especially for systemic injection, is still developing. The confidence in this video outruns the evidence by a meaningful margin.